Literature DB >> 23941661

KLIFS: a knowledge-based structural database to navigate kinase-ligand interaction space.

Oscar P J van Linden1, Albert J Kooistra, Rob Leurs, Iwan J P de Esch, Chris de Graaf.   

Abstract

Protein kinases regulate the majority of signal transduction pathways in cells and have become important targets for the development of designer drugs. We present a systematic analysis of kinase-ligand interactions in all regions of the catalytic cleft of all 1252 human kinase-ligand cocrystal structures present in the Protein Data Bank (PDB). The kinase-ligand interaction fingerprints and structure database (KLIFS) contains a consistent alignment of 85 kinase ligand binding site residues that enables the identification of family specific interaction features and classification of ligands according to their binding modes. We illustrate how systematic mining of kinase-ligand interaction space gives new insights into how conserved and selective kinase interaction hot spots can accommodate the large diversity of chemical scaffolds in kinase ligands. These analyses lead to an improved understanding of the structural requirements of kinase binding that will be useful in ligand discovery and design studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23941661     DOI: 10.1021/jm400378w

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  53 in total

1.  A molecular dynamics investigation of CDK8/CycC and ligand binding: conformational flexibility and implication in drug discovery.

Authors:  Timothy Cholko; Wei Chen; Zhiye Tang; Chia-En A Chang
Journal:  J Comput Aided Mol Des       Date:  2018-05-08       Impact factor: 3.686

2.  Fragment virtual screening based on Bayesian categorization for discovering novel VEGFR-2 scaffolds.

Authors:  Yanmin Zhang; Yu Jiao; Xiao Xiong; Haichun Liu; Ting Ran; Jinxing Xu; Shuai Lu; Anyang Xu; Jing Pan; Xin Qiao; Zhihao Shi; Tao Lu; Yadong Chen
Journal:  Mol Divers       Date:  2015-05-29       Impact factor: 2.943

3.  Delineation of Polypharmacology across the Human Structural Kinome Using a Functional Site Interaction Fingerprint Approach.

Authors:  Zheng Zhao; Li Xie; Lei Xie; Philip E Bourne
Journal:  J Med Chem       Date:  2016-03-17       Impact factor: 7.446

4.  Assessing Lysine and Cysteine Reactivities for Designing Targeted Covalent Kinase Inhibitors.

Authors:  Ruibin Liu; Zhi Yue; Cheng-Chieh Tsai; Jana Shen
Journal:  J Am Chem Soc       Date:  2019-04-16       Impact factor: 15.419

5.  Structural propensities of kinase family proteins from a Potts model of residue co-variation.

Authors:  Allan Haldane; William F Flynn; Peng He; R S K Vijayan; Ronald M Levy
Journal:  Protein Sci       Date:  2016-06-26       Impact factor: 6.725

6.  How Electrostatic Coupling Enables Conformational Plasticity in a Tyrosine Kinase.

Authors:  Cheng-Chieh Tsai; Zhi Yue; Jana Shen
Journal:  J Am Chem Soc       Date:  2019-09-13       Impact factor: 15.419

7.  Conformation-Selective Analogues of Dasatinib Reveal Insight into Kinase Inhibitor Binding and Selectivity.

Authors:  Frank E Kwarcinski; Kristoffer R Brandvold; Sameer Phadke; Omar M Beleh; Taylor K Johnson; Jennifer L Meagher; Markus A Seeliger; Jeanne A Stuckey; Matthew B Soellner
Journal:  ACS Chem Biol       Date:  2016-03-01       Impact factor: 5.100

8.  Determining Cysteines Available for Covalent Inhibition Across the Human Kinome.

Authors:  Zheng Zhao; Qingsong Liu; Spencer Bliven; Lei Xie; Philip E Bourne
Journal:  J Med Chem       Date:  2017-04-04       Impact factor: 7.446

9.  Identification and Optimization of 4-Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase.

Authors:  Christopher R M Asquith; Tuomo Laitinen; James M Bennett; Paulo H Godoi; Michael P East; Graham J Tizzard; Lee M Graves; Gary L Johnson; Ronna E Dornsife; Carrow I Wells; Jonathan M Elkins; Timothy M Willson; William J Zuercher
Journal:  ChemMedChem       Date:  2017-11-27       Impact factor: 3.466

10.  Discovery and biological evaluation of N5-substituted 6,7-dioxo-6,7-dihydropteridine derivatives as potent Bruton's tyrosine kinase inhibitors.

Authors:  Haiyang Chen; Peiran Song; Yanyan Diao; Yongjia Hao; Dou Dou; Wanqi Wang; Xiaoyu Fang; Yanling Wang; Zhenjiang Zhao; Jian Ding; Honglin Li; Hua Xie; Yufang Xu
Journal:  Medchemcomm       Date:  2018-03-13       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.